This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universidade Federal De Minas Gerais. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Roberto Queiroga Lautner
Introduction
Roberto Queiroga Lautner is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. His work focuses on the use of peptides as potential treatments for various diseases.
Latest Patents
Roberto Queiroga Lautner holds one patent related to the peptide Des-[Asp]-[Ala]-Angiotensin-(1-7) (Ala-Arg-Val-Tyr-Ile-His-Pro) (SEQ ID NO: 1). This invention is aimed at utilizing this peptide and its related compounds as vasodilating and cardioprotective agents in mammals. The patent also encompasses the production of compounds containing Des-[Asp]-[Ala]-Angiotensin-(1-7) and their application in methods for treating and preventing diseases.
Career Highlights
Lautner is affiliated with the Universidade Federal De Minas Gerais, where he contributes to research and innovation in the field of health sciences. His academic background and research endeavors have positioned him as a key figure in his area of expertise.
Collaborations
He has collaborated with notable colleagues, including Robson Augusto Souza Dos Santos and Anderson José Ferreira, to advance research initiatives and explore new therapeutic possibilities.
Conclusion
Roberto Queiroga Lautner's work exemplifies the impact of innovative research in the medical field. His contributions through patents and collaborations continue to pave the way for advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile